TRAX
First Tracks Biotherapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
First Tracks Biotherapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
First Tracks Biotherapeutics, Inc.
45.20
−0.03 · −0.06%
post 45.67 +1.04%
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | EcoR1 CapitalEcoR1 Capital | $63.9M | 9.31% | new | |
| 2 | TCG Crossover ManagementTCG Crossover | $58.3M | 8.49% | new | |
| 3 | FMRFMR | $41.3M | 6.03% | new | |
| 4 | Affinity Asset AdvisorsAffinity Asset | $40.9M | 5.96% | new | |
| 5 | BlackRockBlackRockindex-like | $39.5M | 5.76% | new | |
| 6 | Trails Edge Capital PartnersTrails Edge Capital Partners | $30.5M | 4.44% | new | |
| 7 | State StreetState Streetindex-like | $30.4M | 4.44% | new | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $29.2M | 4.26% | new | |
| 9 | Jupiter TopcoJupiter Topco | $22.0M | 3.20% | — | |
| 10 | Vestal Point CapitalVestal Point Capital | $20.4M | 2.97% | new | |
| 11 | Woodline PartnersWoodline Partners | $18.5M | 2.69% | new | |
| 12 | SanofiSanofi | $16.5M | 2.41% | new | |
| 13 | Morgan StanleyMorgan Stanley | $15.7M | 2.29% | new | |
| 14 | 683 Capital Management683 Capital Management | $15.1M | 2.20% | new | |
| 15 | Adage Capital Partners GPAdage Capital Partners GP | $14.7M | 2.14% | new | |
| 16 | Balyasny Asset ManagementBalyasny | $14.4M | 2.10% | new | |
| 17 | Geode Capital ManagementGeodeindex-like | $14.1M | 2.06% | new | |
| 18 | Bank of AmericaBank of America | $13.0M | 1.90% | new | |
| 19 | StemPoint CapitalStemPoint Capital | $12.5M | 1.83% | new | |
| 20 | Palo Alto InvestorsPalo Alto Investors | $12.1M | 1.77% | new | |
| 21 | Sofinnova InvestmentsSofinnova | $11.4M | 1.66% | new | |
| 22 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $11.0M | 1.60% | new | |
| 23 | Goldman Sachs GroupGoldman Sachs | $9.8M | 1.43% | new | |
| 24 | Point72 Asset ManagementPoint72 | $8.2M | 1.20% | new | |
| 25 | UBS GroupUBS | $6.3M | 0.91% | new |
150 managers report $685.9M of First Tracks Biotherapeutics on form 13F for the quarter ended Jun 30 '26. 23 of them hold 80% of it; EcoR1 Capital is largest at 9.31%.
Expected move
No implied move.
No implied move.
No implied move.